Intraductal papilloma of the breast: prevalence of malignancy and natural history under active surveillance

J Limberg, W Kucher, G Fasano, S Hoda… - Annals of Surgical …, 2021 - Springer
Background The optimal management of intraductal papillomas (IPs) without atypia
diagnosed on needle core biopsy (NCB) is unclear. This study analyzed the malignancy risk …
被引用次数：15 相关文章

Intraductal Papilloma of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance.

J Limberg, W Kucher, G Fasano, S Hoda… - Annals of Surgical …, 2021 - europepmc.org
Background The optimal management of intraductal papillomas (IPs) without atypia
diagnosed on needle core biopsy (NCB) is unclear. This study analyzed the malignancy risk …

Intraductal Papilloma of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance

J Limberg, W Kucher, G Fasano… - Annals of surgical …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The optimal management of intraductal papillomas (IPs) without atypia
diagnosed on needle core biopsy (NCB) is unclear. This study analyzed the malignancy risk …

Intraductal Papilloma of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance

J Limberg, K Whitney, G Fasano… - Annals of Surgical …, 2021 - search.proquest.com
Background The optimal management of intraductal papillomas (IPs) without atypia
diagnosed on needle core biopsy (NCB) is unclear. This study analyzed the malignancy risk …